ARCHIVES

Early HER2 Positive Patients At Higher Risk of Recurrence

This article is from The Cancer Letter archive.

Vol. 32 No. 1 | January 30, 2009

Download PDF Visit The Full Archive

Related Articles

Trading In Stock Of U.S. Bioscience Halted, Newsletter Report Cited

October 9, 1992

Urocidin May Provide Alternative To Cystectomy in BCG Cancers

May 27, 2011

FDA Approves Ribavirin Phase 102 Trials

October 30, 1987

Home-Based Program Helps Older Cancer Survivors

May 29, 2009

Schering to Pay $435M to Settle Federal Charges.

January 26, 2007

Obey Continue Crusade On Carcinogenesis, Attack On DCCP, Shubik

April 1, 1977